Thank you to our speakers and sponsors for allowing us to provide an engaging and enlightening agenda.


The agenda:

8:00 to 8:45 a.m.

Hot breakfast, Meet with Sponsors.
A full hot breakfast is waiting for you outside the beautiful Lerner Hall.

8:45 to 9:00 a.m.

Opening remarks & Pre-conference ECS IQ test.
Chris Rokosh, President and CEO of Connect Medical Legal Experts and your MC, welcomes everyone with an overview of the day and a pre-conference quiz that includes 10 questions about the Endocannabinoid System.

9:00 to 9:15 a.m.

Welcome from your Host.
Rob Dhoble, managing director of the international cannabis advisory Havas ECS, offers opening remarks to set the tone for this amazing day of knowledge and networking.

9:15 to 9:30 a.m.

State of the Nation; Cannabis.
Dr. Jahan Marcu, Editor in Chief of the American Journal of Endocannabinoid Medicine, will discuss federal, state and jurisdictional cannabis regulations.

9:30 to 10:15 a.m.

The Science of the Endocannabinoid System.
With a sharp focus on patient safety and harm reduction, Dr. Monica Taing, PharmD, RPh will detail the pharmacology and fundamental components of the Endocannabinoid System (ECS). Learn how the pharmacokinetic and pharmacodynamic considerations of various cannabinoids impact homeostasis, chronic disease states, dosing considerations, formulation selection, drug-drug interactions, plus therapeutic and toxic monitoring parameters. Dr. Taing’s presentation will prepare you for the rest of today’s learning.

10:15 to 10:30 a.m


10:30 to 11:15 a.m.

Current Uses and Delivery Systems.
Philippe Lucas, VP of Global Patient Research & Access at Tilray, will discuss Tilray’s clinical and observational cannabis research program, including patterns of use and the impact of cannabis on the use of opioids and other prescription drugs. Data is from TOPS, the largest national prospective Canadian study of medical cannabis patients, and the presentation will focus on cannabis as a treatment for pain, mental health, addiction, subsequent changes in prescription drug use and improvements in quality of life.

11:15 to 12:00 a.m.

Published Evidence, Current Research.
Dr. Margaret Haney PhD looks at the enormous gap between medical cannabis science and public policy, and some of the issues relevant to physicians who recommend it. She will describe the effects for which cannabis has demonstrated efficacy in placebo-controlled studies, what research looks promising, and discuss the potential risks of recommending cannabis. As societal acceptance of cannabis increases the likelihood of a placebo response biasing perceptions, studies are needed that separate the pharmacologic effect of cannabinoids from the expectancy effect.

12:00 to 12:45 p.m.

Enjoy a hot lunch. Mingle with other attendees, and meet with sponsors.

12:45 to 1:30 p.m.

Potential Drug/Drug, Drug/Disease Interactions.
Welcome Dr. Jahan Marcu, PhD and Editor in Chief of the American Journal of Endocannabinoid Medicine, back to the stage as he describes how cannabinoids can be ‘victims’ or ‘perpetrators’ of a drug-drug interactions. Learn how to predict, identify, or avoid potential drug-drug interactions with cannabis-based products and identify which CYP enzymes are primarily responsible for THC and CBD metabolism.

1:30 to 2:15 p.m.

Potential Prescriber Liabilities.
Attorney Lauren Rudick examines a common theme among healthcare professionals; is recommending medical cannabis to their patients worth the risk? This amazing presentation will examine medical cannabis programs, concerns surrounding physician privacy, potential conflicts of interests, resolving patient problems, dealing with competition, product liability claims, targeting by law enforcement, along with considerations in banking and credit issues.

2:15 to 2:25 p.m.

Retake ECS IQ Quiz
Chris Rokosh will re-test your knowledge of the Endocannabinoid System

2:25 to 2:40 p.m.


2:40 to 4:10 p.m.

The Trial the World's Been Waiting For!
A medical malpractice mock trial involving a doctor, a patient, a fatal accident, and cannabis. It’s the case the world is waiting for and only a matter of time. Be the first ‘jury’ in the nation to determine liability in the case the world is waiting for. Learn the facts, hear the opening arguments, watch the cross examinations. Then consider the medical legal principles of duty, standard of care, dereliction of duty, causation, damages and informed consent as you, the jury, decide the outcome. Don’t miss this!

4:10 to 4:15 p.m.

Closing Remarks
Rob Dhoble will end the day with a brief wrap up.

4:15 to 6:00 p.m.

Networking Wine and Cheese.
Join the conference hosts, speakers, sponsors and fellow attendees in the North Lobby.

Thank you to our sponsors

CME Accreditation


To inform the audience of current science, research and risks related to medical cannabis.


  1. To fill the well identified knowledge gap of physicians and Medical Cannabis.
  2. To increase knowledge of the Endocannabinoid System
  3. To share data on cannabis use, delivery systems and effects on other medications and diseases
  4. To identify potential drug/drug disease interactions                                                  
  5. To discuss and identify potential prescriber liabilities.          


This educational activity is intended for physicians and other healthcare professionals interested in the endocannabinoid system.


Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.


It is the policy of Voxmedia to ensure fair-balance, independence, objectivity, and scientific rigor in all directly or jointly sponsored educational activities. All prospective faculty are required to disclose any significant financial, other interest or relationship (1) with any commercial interest producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients AND (2) with any commercial supporters prior to participating in the planning of an activity or developing content. Only then may faculty receive approval to participate, and are expected to contribute evidence-based material and information. Faculty are required to indicate areas of their presentation that are based on professional opinion vs. guidelines, meta-analysis etc. All information submitted will be peer-reviewed.